W. Jeffrey Allard

15.2k total citations · 7 hit papers
50 papers, 11.8k citations indexed

About

W. Jeffrey Allard is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, W. Jeffrey Allard has authored 50 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 16 papers in Molecular Biology. Recurrent topics in W. Jeffrey Allard's work include Cancer Cells and Metastasis (15 papers), Prostate Cancer Treatment and Research (12 papers) and Prostate Cancer Diagnosis and Treatment (11 papers). W. Jeffrey Allard is often cited by papers focused on Cancer Cells and Metastasis (15 papers), Prostate Cancer Treatment and Research (12 papers) and Prostate Cancer Diagnosis and Treatment (11 papers). W. Jeffrey Allard collaborates with scholars based in United States, Belgium and Netherlands. W. Jeffrey Allard's co-authors include Michael Craig Miller, Leon W.M.M. Terstappen, Jeri Matera, Massimo Cristofanilli, Daniel F. Hayes, Gerald V. Doyle, Alison Stopeck, G. Thomas Budd, Matthew J. Ellis and James M. Reuben and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

W. Jeffrey Allard

50 papers receiving 11.5k citations

Hit Papers

Circulating Tumor Cells, Disease Progression, ... 1985 2026 1998 2012 2004 2004 1985 2005 2006 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
    2004 3.5k citations Massimo Cristofanilli, G. Thomas Budd et al. New England Journal of Medicine profile →
  2. Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases
    2004 2.0k citations W. Jeffrey Allard, Jeri Matera et al. Clinical Cancer Research profile →
  3. Sequence and Structure of a Human Glucose Transporter
    1985 1.3k citations W. Jeffrey Allard et al. profile →
  4. Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer
    2005 857 citations Massimo Cristofanilli, Daniel F. Hayes et al. Journal of Clinical Oncology profile →
  5. Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival
    2006 808 citations Daniel F. Hayes, Massimo Cristofanilli et al. Clinical Cancer Research profile →
  6. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
    2008 641 citations Richard G. Moore, D. Scott McMeekin et al. Gynecologic Oncology profile →
  7. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
    2007 532 citations Richard G. Moore, Amy Brown et al. Gynecologic Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Jeffrey Allard United States 25 6.4k 4.5k 3.3k 2.9k 2.1k 50 11.8k
Jahn M. Nesland Norway 53 4.5k 0.7× 2.3k 0.5× 5.5k 1.6× 3.0k 1.0× 1.3k 0.6× 203 11.4k
F. Jänicke Germany 54 5.5k 0.9× 6.2k 1.4× 3.1k 0.9× 1.6k 0.5× 695 0.3× 183 11.3k
James D. Brenton United Kingdom 47 4.0k 0.6× 6.2k 1.4× 5.9k 1.8× 2.6k 0.9× 462 0.2× 167 12.5k
Britta Weigelt United States 70 8.1k 1.3× 8.4k 1.9× 7.8k 2.3× 3.0k 1.0× 936 0.5× 311 19.1k
Robert G. Bristow Canada 64 4.2k 0.7× 4.0k 0.9× 6.8k 2.0× 4.8k 1.6× 1.3k 0.6× 289 14.1k
Jahn M. Nesland Norway 53 3.7k 0.6× 2.3k 0.5× 3.5k 1.1× 2.2k 0.8× 798 0.4× 194 9.1k
Sabine Riethdorf Germany 62 9.2k 1.4× 7.0k 1.5× 4.7k 1.4× 3.1k 1.1× 2.1k 1.0× 218 14.7k
Ruby Yun‐Ju Huang Singapore 39 7.2k 1.1× 4.8k 1.1× 9.8k 2.9× 2.0k 0.7× 806 0.4× 103 16.4k
Michael I. Koukourakis Greece 60 3.9k 0.6× 5.0k 1.1× 6.1k 1.8× 2.6k 0.9× 769 0.4× 332 13.0k
Alexandra Giatromanolaki Greece 65 4.2k 0.7× 5.9k 1.3× 7.6k 2.3× 2.8k 1.0× 680 0.3× 389 15.3k

Countries citing papers authored by W. Jeffrey Allard

Since Specialization
Citations

This map shows the geographic impact of W. Jeffrey Allard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Jeffrey Allard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Jeffrey Allard more than expected).

Fields of papers citing papers by W. Jeffrey Allard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Jeffrey Allard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Jeffrey Allard. The network helps show where W. Jeffrey Allard may publish in the future.

Co-authorship network of co-authors of W. Jeffrey Allard

This figure shows the co-authorship network connecting the top 25 collaborators of W. Jeffrey Allard. A scholar is included among the top collaborators of W. Jeffrey Allard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Jeffrey Allard. W. Jeffrey Allard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hegmans, Joost P., Joris D. Veltman, Eric T. Fung, et al.. (2009). Protein Profiling of Pleural Effusions to Identify Malignant Pleural Mesothelioma Using SELDI-TOF MS. Technology in Cancer Research & Treatment. 8(5). 323–332. 23 indexed citations
2.
Moore, Richard G., Amy Brown, Michael Craig Miller, et al.. (2008). Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus. Gynecologic Oncology. 110(2). 196–201. 182 indexed citations
3.
Moore, Richard G., D. Scott McMeekin, Amy Brown, et al.. (2008). A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecologic Oncology. 112(1). 40–46. 641 indexed citations breakdown →
4.
Geschwindt, Ryan, Curtis L. Glover, Lý Thị Trần, et al.. (2007). MESOMARK™: A Potential Test for Malignant Pleural Mesothelioma. Clinical Chemistry. 53(4). 666–672. 110 indexed citations
5.
Cohen, Steven J., R. Katherine Alpaugh, Steve Gross, et al.. (2006). Isolation and Characterization of Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 6(2). 125–132. 157 indexed citations
6.
Cristofanilli, Massimo, Daniel F. Hayes, G. Thomas Budd, et al.. (2005). Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer. Journal of Clinical Oncology. 23(7). 1420–1430. 857 indexed citations breakdown →
7.
Almokadem, Salah, Kim Leitzel, Harold A. Harvey, et al.. (2005). Circulating tumor cells in adjuvant breast cancer patients. Journal of Clinical Oncology. 23(16_suppl). 667–667. 4 indexed citations
8.
Allard, W. Jeffrey, Jeri Matera, Michael Craig Miller, et al.. (2004). Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases. Clinical Cancer Research. 10(20). 6897–6904. 2015 indexed citations breakdown →
9.
Allard, W. Jeffrey, Jeri Matera, Michael Craig Miller, et al.. (2004). Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with non-malignant diseases. Journal of Clinical Oncology. 22(14_suppl). 9552–9552. 32 indexed citations
10.
Cristofanilli, Massimo, G. Thomas Budd, Matthew J. Ellis, et al.. (2004). Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer. New England Journal of Medicine. 351(8). 781–791. 3546 indexed citations breakdown →
11.
Hussain, Mushtaq, et al.. (2001). Clinical utility of serum HER-2/neu testing on the Bayer Immuno 1 automated system in breast cancer.. PubMed. 21(2B). 1465–70. 66 indexed citations
12.
13.
Brawer, Michael K., Carol D Cheli, Morton K. Schwartz, et al.. (2000). COMPLEXED PROSTATE SPECIFIC ANTIGEN PROVIDES SIGNIFICANT ENHANCEMENT OF SPECIFICITY COMPARED WITH TOTAL PROSTATE SPECIFIC ANTIGEN FOR DETECTING PROSTATE CANCER. The Journal of Urology. 1476–1480. 7 indexed citations
14.
Cheli, Carol D, et al.. (1999). Measurement of four tumor marker antigens in the sera of pregnant women. Journal of Clinical Laboratory Analysis. 13(1). 35–39. 18 indexed citations
15.
Cheli, Carol D, et al.. (1999). Measurement of four tumor marker antigens in the sera of pregnant women. Journal of Clinical Laboratory Analysis. 13(1). 35–39. 4 indexed citations
16.
Allard, W. Jeffrey, et al.. (1998). Effect of Desialylation on Binding, Affinity, and Specificity of 56 Monoclonal Antibodies against MUC1 Mucin. Tumor Biology. 19(Suppl. 1). 100–110. 20 indexed citations
17.
MEYER, GRANT E., et al.. (1998). Measurement of complexed PSA improves specificity for early detection of prostate cancer. Urology. 52(3). 372–378. 138 indexed citations
18.
Allard, W. Jeffrey, et al.. (1996). Technicon Immuno 1® PSA assay measures both free and alpha-1-antichymotrypsin-complexed prostate-specific antigen on an equimolar basis. Journal of Clinical Laboratory Analysis. 10(3). 155–159. 11 indexed citations
19.
Allard, W. Jeffrey, et al.. (1992). Antigen binding properties of highly purified bispecific antibodies. Molecular Immunology. 29(10). 1219–1227. 13 indexed citations
20.
Allard, W. Jeffrey, Irving S. Sigal, & Richard A. F. Dixon. (1987). Sequence of the gene encoding the human M1 muscarinic acetylcholine receptor. Nucleic Acids Research. 15(24). 10604–10604. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jahn M. Nesland Breakdown of academic impact, for papers by F. Jänicke Breakdown of academic impact, for papers by James D. Brenton Breakdown of academic impact, for papers by Britta Weigelt Breakdown of academic impact, for papers by Robert G. Bristow Breakdown of academic impact, for papers by Jahn M. Nesland Breakdown of academic impact, for papers by Sabine Riethdorf Breakdown of academic impact, for papers by Ruby Yun‐Ju Huang Breakdown of academic impact, for papers by Michael I. Koukourakis Breakdown of academic impact, for papers by Alexandra Giatromanolaki
Rankless by CCL
2026